These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1865022)

  • 1. The effect of heparin on glomerular coagulation induced in mice by cycloheximide and bacterial lipopolysaccharide.
    Parry EW
    J Comp Pathol; 1991 Feb; 104(2):121-7. PubMed ID: 1865022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of endotoxin pretreatment on subsequent challenge of mice with cycloheximide and a small dose of endotoxin.
    Parry EW
    J Comp Pathol; 1989 Nov; 101(4):381-8. PubMed ID: 2607012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further analysis of lethal factors in cycloheximide-treated mice given low doses of bacterial lipopolysaccharide.
    Parry EW
    J Comp Pathol; 1989 Feb; 100(2):155-60. PubMed ID: 2715398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of glucocorticosteroid and of fibrinolytic activity in the development of bilateral renal cortical necrosis in cycloheximide-treated mice challenged with a submicrogram dose of endotoxin.
    Parry EW
    J Comp Pathol; 1989 May; 100(4):405-10. PubMed ID: 2760273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors involved in the fatal susceptibility to submicrogram doses of endotoxin in cycloheximide-treated mice.
    Parry EW
    J Comp Pathol; 1989 Jan; 100(1):13-8. PubMed ID: 2645318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
    Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
    Tomikawa M
    Thromb Diath Haemorrh; 1975 Sep; 34(1):145-58. PubMed ID: 1188708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cycloheximide, heparin and ancrod on mice given Ehrlich ascites tumour cells intravenously.
    Parry EW
    J Comp Pathol; 1985 Apr; 95(2):203-7. PubMed ID: 3837790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil production of tissue factor.
    Lerner RG; Goldstein R; Cummings G
    Thromb Res; 1977 Aug; 11(2):253-61. PubMed ID: 905976
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of heparin as a protective agent following reduction of renal mass.
    Olson JL
    Kidney Int; 1984 Feb; 25(2):376-82. PubMed ID: 6727132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of heparin, epsilon aminocaproic acid, or both agents to prevent increased fibrinogen levels after endotoxin in rabbits.
    Logan LJ; Rapaport SI; Kuefler P
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):321-3. PubMed ID: 4566763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of heparin on coagulation and fibrinolysis during experimental endotoxin shock (author's transl)].
    Kitajima T; Sakuma M; Shikakura K; Ogata H; Sato M
    Masui; 1978 Mar; 27(3):246-52. PubMed ID: 650864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
    Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced breast cancer with chemotherapeutics and inhibition of coagulation and fibrinolysis.
    Astedt B; Mattsson W; Tropé C
    Acta Med Scand; 1977; 201(5):491-3. PubMed ID: 899870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecperimental studies on coagulation-fibrinolytic activity of white blood cells influenced by endotoxin.
    Sakuragawa N; Takahashi K; Yoshiyama M; Jimbo C; Niiya K
    Thromb Res; 1976 Jun; 8(6):887-91. PubMed ID: 960060
    [No Abstract]   [Full Text] [Related]  

  • 16. A prolonged period of uninterrupted protein synthesis is essential for survival in mice given a submicrogram dose of bacterial endotoxin.
    Parry EW
    J Comp Pathol; 1993 Nov; 109(4):429-32. PubMed ID: 8106671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lethal syndrome in mice following administration of carbon tetrachloride and cycloheximide, and its prevention by heparin treatment.
    Parry EW
    J Comp Pathol; 1984 Oct; 94(4):505-8. PubMed ID: 6512024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorrhagic necrosis of the intestinal mucosa associated with disseminated intravascular coagulation.
    Kondo M; Yoshikawa T; Takemura S; Yokoe N; Kawai K; Masuda M
    Digestion; 1978; 17(1):38-45. PubMed ID: 627319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of small doses of heparin in a complex tatment of patients with pneumocarditis on the blood coagulation and fibrinolytic system].
    Aizenberg AA; Gritsiuk AI
    Sov Med; 1969 Feb; 32(2):33-9. PubMed ID: 5380421
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.